High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors

Seasonal influenza infects approximately 10–20% of Canadians each year, causing an estimated 12,200 hospitalizations and 3,500 deaths annually, mostly occurring in adults ≥65 years old (seniors). A 32,000-participant, randomized controlled clinical trial (FIM12; Clinicaltrials.gov NCT01427309) showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Debbie L., Chit, Ayman, DiazGranados, Carlos A., Maschio, Michael, Yau, Eddy, Drummond, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215371/
https://www.ncbi.nlm.nih.gov/pubmed/27669017
http://dx.doi.org/10.1080/21645515.2016.1215395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215371/
https://www.ncbi.nlm.nih.gov/pubmed/27669017
http://dx.doi.org/10.1080/21645515.2016.1215395

Ejemplares similares